Meng, L., Yang, Y. A., Chowdhury, S. M., Hong, E. F., Khorasanchi, A., Mortazavi, A., Singer, E. A., Wang, S., Gauntner, T. D., Collier, K. A., Wang, P., Zimmerman, D. E., Bicer, F., Folefac, E., Hasanov, E., Monk, P., Clinton, S. K. (2026). Circulating tumor DNA dynamics as a predictive biomarker of response and survival in metastatic urothelial carcinoma treated with enfortumab vedotin and pembrolizumab.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.860